Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
An Unwarranted Attack On Rare Disease Research
Forbes
Tue, 08/28/18 - 09:59 am
R&D
Rare Diseases
Pain Therapeutics' Shares Rally on Alzheimer's Study Grant
Yahoo/Zacks.com
Thu, 08/16/18 - 12:52 pm
Pain Therapeutics
NIH
R&D
Alzheimer's disease
PTI-125
Drugmakers say R&D spending hit record in 2017
Biopharma Dive
Mon, 08/13/18 - 11:11 am
R&D
PhRMA
Constrained peptides’ time to shine?
Nature
Mon, 07/30/18 - 11:21 pm
drug development
clinical trials
R&D
contstrained peptides
Brain’s lymphatic system, just recently discovered, now linked to aging and Alzheimer’s
Fierce Biotech
Sat, 07/28/18 - 12:30 pm
Alzheimer's disease
lymphatic system
drug discovery
R&D
Amgen R&D chief Sean Harper hits the exits with a one-way ticket to early-stage biotech
Endpoints
Thu, 07/26/18 - 07:06 pm
Amgen
R&D
Sean Harper
biotech
Glaxo’s New Research Chief Loves Big Pharma. Now He Has To Fix It
Forbes
Tue, 07/24/18 - 11:18 am
GSK
Hal Barron
R&D
According to new market survey, pharma industry continues to invest heavily on basic research
GoinPharma
Thu, 07/12/18 - 09:22 am
R&D
Boehringer Ingelheim
Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs
Endpoints
Wed, 07/11/18 - 10:57 pm
Novartis
R&D
antibiotics
antivirals
layoffs
Ironwood’s preparation for activist-driven R&D split puts 40 staffers out of work
Fierce Pharma
Thu, 07/5/18 - 07:41 pm
Ironwood Pharmaceuticals
R&D
layoffs
Sanofi gets serious in China with plans to hire 300 for $76M R&D site in Chengdu
Endpoints
Mon, 07/2/18 - 10:38 pm
China
Sanofi
clinical trials
R&D
Boehringer backs €20B R&D game plan with a $272M blueprint for new facility — 100 new hires
Endpoints
Fri, 06/22/18 - 10:23 am
Boehringer Ingelheim
R&D
Germany
Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs
Yahoo/Zacks.com
Wed, 06/20/18 - 10:20 pm
Novo Nordisk
R&D
Kallyope
diabetes
obesity
Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Endpoints
Tue, 06/19/18 - 10:53 am
Rhythm Pharmaceuticals
R&D
obesity
Vertex doubles size of cystic fibrosis drug discovery site
Fierce Biotech
Tue, 06/19/18 - 10:09 am
Vertex Pharmaceuticals
R&D
drug development
cystic fibrosis
CrownBio and Pierre Fabre Partner to Advance Development of Immuno-Oncology Therapies
CP Wire
Tue, 06/19/18 - 10:03 am
Crown Bioscience
Pierre Fabre
R&D
immuno-oncology
Axial Biotherapeutics and Parkinson’s Institute Partner to Study GI Metabolites That May Contribute to Parkinson’s Disease
CP WIre
Mon, 06/18/18 - 09:37 am
Axial Biotherapeutics
Parkinson's Disease
R&D
Eisai is building a bespoke Cambridge research center with a $100M-plus plan to find new ways to tackle Alzheimer’s
Endpoints
Wed, 06/13/18 - 09:37 am
Eisai
R&D
Cambridge MA
Alzheimer's disease
Roche CEO Severin Schwan isn’t about to tamper with a winning R&D strategy now, but he’s still looking for ways to cut costs
Endpoints
Tue, 06/12/18 - 10:31 pm
Roche
Pharma CEOs
Severin Schwan
R&D
Pharma R&D Investments Moderating -- But Still High
Forbes
Tue, 06/12/18 - 09:40 am
R&D
drug development
Pages
« first
‹ previous
…
35
36
37
38
39
40
41
42
43
…
next ›
last »